Joshi Alumkal

Associate Professor

  • 2274 Citations
  • 22 h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgen Receptors Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
docetaxel Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Epigenomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2002 2019

Castration
Lysine
Prostatic Neoplasms
Cell Survival
Histones

PACIFIC NORTHWEST PROSTATE CANCER SPORE

Garzotto, M., Alumkal, J., Higano, C., Hood, L., Lange, P., Plymate, S., Mostaghel, E., Vessella, R. L., Etzioni, R., Gleave, M., Yu, E. Y. -., Stanford, J., Nelson, P. & Etzioni, R.

National Institutes of Health

9/19/028/31/18

Project: Research project

Androgen Receptors
Prostate
Prostatic Neoplasms
Radiation Effects
Radiation

Research Output 2004 2019

BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer

Coleman, D. J., Gao, L., King, C. J., Schwartzman, J., Urrutia, J., Sehrawat, A., Tayou, J., Balter, A., Burchard, J., Chiotti, K. E., Derrick, D. S., Sun, D., Xia, Z., Heiser, L. & Alumkal, J., Jan 1 2019, In : Oncogene.

Research output: Contribution to journalArticle

Androgen Receptors
Castration
Prostatic Neoplasms
RNA Sequence Analysis
Neoplasms
1 Citation (Scopus)

Epigenetic therapy with panobinostat combined with bicalutamide rechallenge in castration-resistant prostate cancer

Ferrari, A. C., Alumkal, J., Stein, M. N., Taplin, M. E., Babb, J., Barnett, E. S., Gomez-Pinillos, A., Liu, X., Moore, D., DiPaola, R. & Beer, T. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 52-63 12 p.

Research output: Contribution to journalArticle

Castration
Epigenomics
Prostatic Neoplasms
Arm
Androgen Receptors
1 Citation (Scopus)

Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer

Coleman, D. J., Gao, L., Schwartzman, J., Korkola, J., Sampson, D., Derrick, D. S., Urrutia, J., Balter, A., Burchard, J., King, C. J., Chiotti, K. E., Heiser, L. & Alumkal, J., Dec 1 2019, In : Scientific Reports. 9, 1, 3823.

Research output: Contribution to journalArticle

Open Access
Castration
Prostatic Neoplasms
Maintenance
Androgen Receptors
Cell Line

Reply to a. Dalla volta et al

Aggarwal, R., Huang, J., Alumkal, J., Feng, F. Y., Zhang, L., Stuart, J. M. & Small, E. J., Feb 1 2019, In : Journal of Clinical Oncology. 37, 4, p. 351-352 2 p.

Research output: Contribution to journalLetter

26 Citations (Scopus)

Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: A multi-institutional prospective study

Aggarwal, R., Huang, J., Alumkal, J., Zhang, L., Feng, F. Y., Thomas, G., Weinstein, A. S., Friedl, V., Zhang, C., Witte, O. N., Lloyd, P., Gleave, M., Evans, C. P., Youngren, J., Beer, T. T., Rettig, M., Wong, C. K., True, L., Foye, A., Playdle, D. & 11 othersRyan, C. J., Lara, P., Chi, K. N., Uzunangelov, V., Sokolov, A., Newton, Y., Beltran, H., Demichelis, F., Rubin, M. A., Stuart, J. M. & Small, E. J., Aug 20 2018, In : Journal of Clinical Oncology. 36, 24, p. 2492-2503 12 p.

Research output: Contribution to journalArticle

Neuroendocrine Cells
Prostatic Neoplasms
Prospective Studies
Castration
Therapeutics